Skip to main content
Equibles

HRT FINANCIAL LP

Position in INCY — Incyte Corp

CIK 1475597 NEW YORK, NY
Back to INCY Full portfolio

Position in INCY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,966,364
+$9,819,553 QoQ
Shares Held
149,668
+44.6% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#127
of 855 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. INCY ranks #14 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,089,376 $81,136,724
2 INSM
INSMED Inc
 689,981 $73,565,774
3 EXEL
Exelixis, Inc.
 929,242 $50,560,057
4 MDGL
Madrigal Pharmaceuticals, Inc.
 84,634 $45,444,226
5 AXSM
Axsome Therapeutics, Inc.
 178,491 $43,689,242
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 498,655 $40,645,369
7 ABVX
Abivax S.A.
 270,612 $36,061,755
8 TGTX
Tg Therapeutics, Inc.
 622,603 $34,205,808

All Filings in INCY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,966,364 149,668
2024-12-31 $7,146,811 103,472
2024-09-30 $21,685,360 328,069
2024-06-30 $28,688,899 473,258
2024-03-31 $10,464,078 183,677
2023-12-31 $11,462,754 182,557
2023-09-30 $6,083,238 105,301
2023-06-30 $7,781,374 125,002
2022-12-31 $5,801,593 72,231
2022-06-30 $7,015,601 92,347
2021-12-31 $25,562,871 348,268
2021-06-30 $5,001,865 59,454